Progression of structural neuropathology in preclinical Huntington’s disease: a tensor based morphometry study
暂无分享,去创建一个
J. Ashburner | N. Mahant | C. Kipps | E. McCusker | A. Duggins | L. Gomes
[1] F. Walker. Huntington's disease , 2007, The Lancet.
[2] B. Harper. Huntington Disease , 2005, Journal of the Royal Society of Medicine.
[3] J. Brandt,et al. Onset and rate of striatal atrophy in preclinical Huntington disease , 2004, Neurology.
[4] J Kassubek,et al. Topography of cerebral atrophy in early Huntington’s disease: a voxel based morphometric MRI study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[5] D. Mann,et al. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy , 2004, Acta Neuropathologica.
[6] S. DeKosky,et al. Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders , 2003, Science.
[7] S. Hersch,et al. Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice , 2003, Journal of neurochemistry.
[8] C. Ayuso,et al. Huntington disease–unaffected fetus diagnosed from maternal plasma using QF‐PCR , 2003, Prenatal diagnosis.
[9] C D Good,et al. The distribution of structural neuropathology in pre-clinical Huntington's disease. , 2002, Brain : a journal of neurology.
[10] A. Dale,et al. Regional and progressive thinning of the cortical ribbon in Huntington’s disease , 2002, Neurology.
[11] A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease , 2001, Neurology.
[12] R H Myers,et al. Quantitative neuropathological changes in presymptomatic Huntington's disease , 2001, Annals of neurology.
[13] S. Hersch,et al. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease , 2000, Nature Medicine.
[14] E. Siemers,et al. Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene. , 2000, Archives of neurology.
[15] Karl J. Friston,et al. Voxel-Based Morphometry—The Methods , 2000, NeuroImage.
[16] G. Pearlson,et al. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.
[17] Huntington's disease: A predictor of pathology , 2000, Nature.
[18] R. Shadmehr,et al. Motor disorder in Huntington's disease begins as a dysfunction in error feedback control , 2000, Nature.
[19] Huntington’s disease: neurological assessment of potential gene carriers presenting for predictive DNA testing , 2000, Journal of Clinical Neuroscience.
[20] Karl J. Friston,et al. Image registration using a symmetric prior—in three dimensions , 1999, Human brain mapping.
[21] J. Brandt,et al. Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease. , 1999, Brain : a journal of neurology.
[22] E. Siemers,et al. Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. , 1999, Archives of neurology.
[23] G. M. Halliday,et al. Regional Specificity of Brain Atrophy in Huntington's Disease , 1998, Experimental Neurology.
[24] J. Heinrich,et al. Nocturnal TSH Surge and TRH Test Response in the Evaluation of Thyroid Axis in Hypothalamic Pituitary Disorders in Childhood , 1998, Hormone Research in Paediatrics.
[25] Nick C Fox,et al. Modeling brain deformations in Alzheimer disease by fluid registration of serial 3D MR images. , 1998, Journal of computer assisted tomography.
[26] A E Rosser,et al. Evidence for specific cognitive deficits in preclinical Huntington's disease. , 1998, Brain : a journal of neurology.
[27] G. Pearlson,et al. Frontal lobe volume in patients with Huntington's disease , 1998, Neurology.
[28] D. Zee,et al. Ocular motor abnormalities in Huntington's disease , 1997, Vision Research.
[29] G. Pearlson,et al. Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. , 1996, Archives of neurology.
[30] Jane S. Paulsen,et al. Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.
[31] Jane S. Paulsen,et al. Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.
[32] R. Albin. Selective neurodegeneration in Huntington's disease , 1995, Annals of neurology.
[33] S. Folstein,et al. Early Loss of Neostriatal Striosome Neurons in Huntington's Disease , 1995, Journal of neuropathology and experimental neurology.
[34] L. Wilkins. Guidelines for the molecular genetics predictive test in Huntington's disease , 1994, Neurology.
[35] J. Brandt,et al. Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at‐risk persons , 1994, Neurology.
[36] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[37] J C Mazziotta,et al. Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease. , 1992, Archives of neurology.
[38] J. Penney,et al. Preferential loss of striato‐external pallidal projection neurons in presymptomatic Huntington's disease , 1992, Annals of neurology.
[39] J. Vonsattel,et al. Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease , 1988, Journal of neuropathology and experimental neurology.
[40] J. Penney,et al. Differential loss of striatal projection neurons in Huntington disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[41] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[42] R. Roos,et al. Neuronal distribution in the putamen in Huntington's disease. , 1985, Journal of neurology, neurosurgery, and psychiatry.
[43] G. Graveland,et al. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. , 1985, Science.
[44] K. F. Schroeder,et al. Morphometric studies of the neuropathological changes in choreatic diseases , 1976, Journal of the Neurological Sciences.